[HTML][HTML] Development and pharmacokinetic evaluation of a self-nanoemulsifying drug delivery system for the oral delivery of cannabidiol
LY Kok, P Bannigan, F Sanaee, JC Evans… - European Journal of …, 2022 - Elsevier
The number of lipophilic drug candidates in pharmaceutical discovery pipelines has
increased in recent years. These drugs often possess physicochemical properties that result …
increased in recent years. These drugs often possess physicochemical properties that result …
Development and pharmacokinetic evaluation of a self-nanoemulsifying drug delivery system for the oral delivery of cannabidiol.
LY Kok, P Bannigan, F Sanaee, JC Evans… - European Journal of …, 2021 - europepmc.org
The number of lipophilic drug candidates in pharmaceutical discovery pipelines has
increased in recent years. These drugs often possess physicochemical properties that result …
increased in recent years. These drugs often possess physicochemical properties that result …
[PDF][PDF] Development and Pharmacokinetic Evaluation of a Self-Nanoemulsifying Drug Delivery System for the Oral Delivery of Cannabidiol
LY Kok, P Bannigan, F Sanaee, JC Evans, M Dunne… - pharmaexcipients.com
The number of lipophilic drug candidates in pharmaceutical discovery pipelines has
increased in recent years. These drugs often possess physicochemical properties that result …
increased in recent years. These drugs often possess physicochemical properties that result …
Development and pharmacokinetic evaluation of a self-nanoemulsifying drug delivery system for the oral delivery of cannabidiol
LY Kok, P Bannigan, F Sanaee… - … : official journal of …, 2022 - pubmed.ncbi.nlm.nih.gov
The number of lipophilic drug candidates in pharmaceutical discovery pipelines has
increased in recent years. These drugs often possess physicochemical properties that result …
increased in recent years. These drugs often possess physicochemical properties that result …
Development and Pharmacokinetic Evaluation of a Self-Nanoemulsifying Drug Delivery System for the Oral Delivery of Cannabidiol
LY Kok - 2021 - search.proquest.com
Cannabidiol (CBD) is a non-psychoactive cannabinoid with a notable safety profile. An oral
formulation of CBD (Epidiolex®) has been approved by the FDA, and there is some …
formulation of CBD (Epidiolex®) has been approved by the FDA, and there is some …
[PDF][PDF] Development and Pharmacokinetic Evaluation of a Self-Nanoemulsifying Drug Delivery System for the Oral Delivery of Cannabidiol
LY Kok, P Bannigan, F Sanaee, JC Evans, M Dunne… - ywsourcingfair.com
The number of lipophilic drug candidates in pharmaceutical discovery pipelines has
increased in recent years. These drugs often possess physicochemical properties that result …
increased in recent years. These drugs often possess physicochemical properties that result …
Development and Pharmacokinetic Evaluation of a Self-nanoemulsifying Drug Delivery System for the Oral Delivery of Cannabidiol
LY Kok - tspace.library.utoronto.ca
Cannabidiol (CBD) is a non-psychoactive cannabinoid with a notable safety profile. An oral
formulation of CBD (Epidiolex®) has been approved by the FDA, and there is some …
formulation of CBD (Epidiolex®) has been approved by the FDA, and there is some …